Anzeige
Meldung des Tages: Das Triple-Discovery-Setup, das der Markt noch nicht begriffen hat!!

Skye Bioscience News

Aktie
WKN:  A3ES4X ISIN:  US83086J2006 US-Symbol:  SKYE Branche:  Biotechnologie Land:  USA
0,8068 $
+0,0771 $
+10,57%
0,6950 € 20:58:39 Uhr
Depot/Watchlist
Marktkapitalisierung *
20,62 Mio. €
Streubesitz
35,69%
KGV
-4,29
Index-Zuordnung
-

Skye Bioscience News

19.01.26 - PR Newswire
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE PR Newswire
19.01.26 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
16.01.26 - PR Newswire
SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire
15.01.26 - PR Newswire
Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026 Deadline to Join - Contact The Gross Law Firm PR Newswire
14.01.26 - PR Newswire
Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE PR Newswire
14.01.26 - PR Newswire
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE PR Newswire
14.01.26 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
13.01.26 - PR Newswire
FRIDAY DEADLINE: Berger Montague Advises Skye Bioscience, Inc. (NASDAQ: SKYE) Investors to Inquire About a Securities Fraud Class Action by January 16, 2026
FRIDAY DEADLINE: Berger Montague Advises Skye Bioscience, Inc. (NASDAQ: SKYE) Investors to Inquire About a Securities Fraud Class Action by January 16, 2026 PR Newswire
11.01.26 - PR Newswire
SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire
09.01.26 - PR Newswire
Investors who lost money on Skye Bioscience, Inc.(SKYE) should contact Levi & Korsinsky about pending Class Action - SKYE
Investors who lost money on Skye Bioscience, Inc.(SKYE) should contact Levi & Korsinsky about pending Class Action - SKYE PR Newswire
08.01.26 - PR Newswire
Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE
Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE PR Newswire
06.01.26 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire
06.01.26 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire
06.01.26 - PR Newswire
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm PR Newswire
06.01.26 - PR Newswire
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience PR Newswire
06.01.26 - PR Newswire
Skye Bioscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE
Skye Bioscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE PR Newswire
05.01.26 - PR Newswire
The Gross Law Firm Notifies Shareholders of Skye Bioscience, Inc.(SKYE) of a Class Action Lawsuit and an Upcoming Deadline
The Gross Law Firm Notifies Shareholders of Skye Bioscience, Inc.(SKYE) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire
05.01.26 - PR Newswire
Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity
Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-​Formulated with ENHANZE® for Obesity PR Newswire
02.01.26 - PR Newswire
Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky PR Newswire
01.01.26 - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience PR Newswire

Newssuche

Videos

newspaper
10:40 Uhr +38,58%
Technical Trading: DAX Long Chance
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »